| |
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910957531703321 |
|
|
Autore |
Belhocine Nazim |
|
|
Titolo |
Treating Intangible Inputs as Investment Goods : : The Impact on Canadian GDP / / Nazim Belhocine |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C. : , : International Monetary Fund, , 2009 |
|
|
|
|
|
|
|
ISBN |
|
9786612844409 |
9781462399147 |
1462399142 |
9781452700618 |
1452700613 |
9781451873870 |
1451873875 |
9781282844407 |
1282844407 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Gross domestic product - Canada - Econometric models |
Labor productivity - Canada - Econometric models |
Investments - Canada - Econometric models |
Capacity |
Capital |
Computer Programs: General |
Data capture & analysis |
Data Collection and Data Estimation Methodology |
Data collection |
Data Processing |
Data processing |
Databases |
Economic statistics |
Electronic data processing |
Expenditure |
Expenditures, Public |
General Aggregative Models: General |
Intangible Capital |
Intangible capital |
Investment |
Investments: General |
Macroeconomics |
|
|
|
|
|
|
|
|
|
|
|
|
National accounts |
National Government Expenditures and Related Policies: General |
National income |
Public finance & taxation |
Public Finance |
Saving and investment |
Canada |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
Nota di contenuto |
|
Intro -- Table of Contents -- I. Introduction -- II. National Accounts' Conventions and the Rationale Against it -- III. Data Collection Approach -- IV. Data Sources -- A. Computerized Information -- B. Innovative Property -- C. Economic Competencies -- V. Summary of Findings and Comparison with Other Countries -- A. Findings for Canada -- B. Comparison with the U.S. and the U.K -- VI. Impact of Including Intangibles on GDP -- VII. Conclusion -- References -- Tables -- 1. Decomposition of Intangible Expenditures by Item -- 2. Comparison of Expenditures in Intangibles Across U.S., U.K. and Canada -- 3. Impact of Including Intangibles on Real GDP Growth -- Figures -- 1. Software Investment (overall and by type) -- 2. Tangible Versus Intangible Investment. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This paper constructs a data set to document firms' expenditures on an identifiable list of intangible items and examines the implications of treating intangible spending as an acquisition of final (investment) goods on GDP growth for Canada. It finds that investment in intangible capital by 2002 is almost as large as the investment in physical capital. This result is in line with similar findings for the U.S. and the U.K. Furthermore, the growth in GDP and labor productivity may be underestimated by as much as 0.1 percentage point per year during this same period. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910557644303321 |
|
|
Autore |
Pitsikas Nikolaos |
|
|
Titolo |
Crocus sativus L. Extract and Its Constituents: Chemistry, Pharmacology and Therapeutic Potential |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (171 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Natural products or organic compounds isolated from natural sources as primary or secondary metabolites have inspired numerous drugs. It is not an overstatement that the majority of medicines in clinics, even in the 21st century, have been derived from natural resources despite the decline of industry research into natural products due to a variety of drawbacks. Saffron crocus, considered to be the most valuable spice by weight, and its bioactive constituents, have been studied for the treatment of a wide range of pathologies, including neuropsychiatric and neurodegenerative disorders, cancer, diabetes, and even cardiovascular diseases. In this book on the chemistry, pharmacology, and therapeutic potential of Crocus sativus L. extract and its constituents, we aimed to assess new advances in the understanding of the therapeutic action of saffron and its constituents in targeting different pathologies. In this context, eight original research articles covering recent advances in the therapeutic actions of saffron and its ingredients in different diseases are reported. Two studies reporting novel methods regarding the bioanalysis of saffron extracts have been included. The collection is completed with two very interesting reviews reporting advances in the fields of schizophrenia and cancer. In conclusion, in this book, we are delighted to have received several contributions that we hope will provide new and interesting information for the scientific community on the chemistry, pharmacology, and |
|
|
|
|
|
|
|
|
|
|
therapeutic potential of Crocus sativus L. extract and its constituents. |
|
|
|
|
|
| |